supp.fit
All Red Yeast Rice study protocols

Red Yeast Rice and Coenzyme Q10: study protocols

11 study groups took Red Yeast Rice together with Coenzyme Q10. These are the doses the studies gave. They are not a recommendation.

Red Yeast Rice: what the research found →

Dose per serving from research: Red Yeast Rice

11 study groups in 9 studies say how much Red Yeast Rice participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 5 mg to 10 mg and 100 mg to 250 mg, 45% of 11 study groups each.

Daily doseStudy groups
5 mg or less
1
5 mg to 10 mg
5
10 mg to 25 mg
0
25 mg to 50 mg
0
50 mg to 100 mg
0
100 mg to 250 mg
5

Dose per serving from research: Coenzyme Q10

9 study groups in 8 studies say how much Coenzyme Q10 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 mg to 2.5 mg, 56% of 9 study groups.

Daily doseStudy groups
1 mg to 2.5 mg
5
2.5 mg to 5 mg
0
5 mg to 10 mg
0
10 mg to 25 mg
2
25 mg to 50 mg
2

Commonly used together

10 of 11 study groups took Red Yeast Rice and Coenzyme Q10 with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Berberine
5
Folic Acid
5
Policosanol
4
Astaxanthin
3

11 study groups

Study
Effect of Monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndrome
2018 · treatment group · Adults with metabolic syndrome who had hypertension and hypercholesterolemia; mean age 57.4 years
10 mg30 mg60 days—
Low Dose Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts Lowers LDL Cholesterol in Patients with Mild Dyslipidemia: A Multicenter, Randomized Controlled Trial
2023 · Group A (10 mg monacolin) · Adults over 40 years with mild hypercholesterolemia (fasting LDL-C 140–180 mg/dL) and low cardiovascular risk
10 mg—8 weeks39
Low Dose Monacolin K Combined with Coenzyme Q10, Grape Seed, and Olive Leaf Extracts Lowers LDL Cholesterol in Patients with Mild Dyslipidemia: A Multicenter, Randomized Controlled Trial
2023 · Group B (3 mg monacolin) · Adults over 40 years with mild hypercholesterolemia (fasting LDL-C 140–180 mg/dL) and low cardiovascular risk
3 mg—8 weeks33
Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial
2015 · Combination A · Adults aged 18–70 with hypercholesterolemia not requiring statins or statin-intolerant
200 mg2 mg4 weeks23
Nutraceutical approach for the management of cardiovascular risk - a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study
2019 · Nutraceutical combination · Adults aged 18–70 with low cardiovascular risk, in primary cardiovascular prevention, and LDL-C of 130–200 mg/dL
10 mg20 mg12 weeks16
Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q(10) on lipid levels: a randomized, double-blind, placebo controlled study
2017 · Body Lipid (BL) · Adults aged 18–75, both sexes, with mild-to-moderate hypercholesterolemia
10 mg2 mg4 weeks—
Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q(10) on lipid levels: a randomized, double-blind, placebo controlled study
2017 · Armolipid Plus (AM) · Adults aged 18–75, both sexes, with mild-to-moderate hypercholesterolemia
200 mg2 mg4 weeks—
Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial
2014 · Intervention (Armolipid Plus/AP) · Men and women older than 18 years with mild-moderate hypercholesterolemia and elevated LDL-c, candidates for lifestyle intervention without hypolipemic drug treatment
200 mg2 mg12 weeks51
Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial
2017 · Active nutraceutical · Adults aged 25–75 with moderately elevated cholesterol and metabolic syndrome, in primary cardiovascular prevention
200 mg50 mg6 weeks30
Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial
2019 · Nutraceutical B · Adults aged 18–75 with elevated serum cholesterol not requiring statins or statin-intolerant; people with cardiovascular disease and uncontrolled diabetes were excluded.
200 mg2 mg6 weeks23
Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study)
2021 · nutraceutical combination · Adults aged 18–70 with moderate hypercholesterolemia, in primary cardiovascular prevention
10 mg20 mg12 weeks16
Red Yeast Rice and Coenzyme Q10: study protocols | supp.fit